Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
The Axcelis Technologies Inc (ACLS) news page on Stock Titan aggregates company announcements, industry event participation and regulatory disclosures focused on its role in the semiconductor equipment market. Axcelis describes itself as a leading supplier of enabling ion implantation solutions for the semiconductor industry, with more than 45 years of experience providing high-productivity systems and lifecycle support.
Investors and industry followers can use this page to monitor Axcelis’ updates on product launches, technology platforms and market engagement. Recent news has highlighted the introduction of the Purion Power Series+ ion implant platform for next generation power devices, including silicon carbide (SiC) power devices and superjunction architectures, as well as the GSD Ovation ES high current implanter for engineered substrates. Company releases also cover its participation in major industry events such as SEMICON Japan and the International Conference on Silicon Carbide and Related Materials (ICSCRM), where Axcelis technologists present technical work on SiC and related materials.
The feed also includes financial and corporate developments, such as quarterly results announcements, conference call schedules and Axcelis’ participation in investor conferences. A significant recent development is the all-stock merger agreement with Veeco Instruments Inc., under which Veeco is expected to become a wholly owned subsidiary of Axcelis, subject to regulatory and shareholder approvals.
By following this ACLS news page, readers can track Axcelis’ communications on its ion implantation product portfolio, aftermarket strategy, global customer engagement and planned combination with Veeco, all drawn from official press releases and SEC-referenced materials.
Axcelis Technologies, Inc. (Nasdaq: ACLS) will release its financial results for Q1 2023 on May 3, 2023, at 4:00 p.m. ET, followed by a conference call on May 4, 2023, at 8:30 a.m. ET. Interested parties can access the call via an audio webcast on Axcelis' Investors page. The company, headquartered in Beverly, Massachusetts, specializes in high-productivity solutions for the semiconductor industry, focusing on ion implantation systems and complete life cycle support. For more information, visit www.axcelis.com.
Axcelis Technologies (Nasdaq: ACLS) announced the significant milestone of shipping its 500th Purion™ ion implanter system to a major semiconductor manufacturer in North America. This achievement underscores Axcelis' market leadership in providing ion implantation solutions for the semiconductor industry. According to President and CEO Mary Puma, this shipment validates the company’s strong customer partnerships and expanding manufacturing capabilities. The growing installed base of Purion systems is expected to bolster Axcelis' aftermarket business. The Purion platform is recognized for its advanced technology, particularly in image sensor and power device manufacturing.
Axcelis Technologies (Nasdaq: ACLS) has appointed Russell J. Low, Ph.D., as President and CEO effective May 11, 2023. He will succeed Mary G. Puma, who will become Executive Chairperson and remain a Senior Advisor. Dr. Low, previously Executive VP of Global Customer Operations and Engineering, played a key role in developing the Purion ion implant product line. Puma, who has led Axcelis for 22 years, emphasized the timing for this transition as ideal for future growth. The board expressed confidence in Dr. Low's leadership, highlighting his technical expertise and commitment to innovation, promising continued market leadership and value delivery.
Axcelis Technologies (NASDAQ: ACLS) announced on March 12, 2023, that the recent collapse of Silicon Valley Bank (SVB) is expected to have an immaterial impact on its operations. The company has an unused line of credit with SVB and maintains banking relationships with multiple US and foreign banks. As of December 31, 2022, Axcelis had $185.6 million in cash and cash equivalents, with $246.6 million in short-term investments primarily in U.S. Government securities. The company's liquidity will remain unaffected, and it has instructed clients to remit payments to non-SVB accounts.
Axcelis Technologies, Inc. (NASDAQ: ACLS), a semiconductor equipment supplier, announced on March 12, 2023, that the recent collapse of Silicon Valley Bank (SVB) will have an immaterial impact on its operations. The company highlighted its robust banking relationships with multiple U.S. and foreign banks, ensuring no liquidity issues. As of December 31, 2022, Axcelis held $185.6 million in cash and cash equivalents, alongside $246.6 million in short-term investments in U.S. Government and Agency securities. The company is taking steps to move deposits and ensure customer payments are unaffected.
Axcelis Technologies (Nasdaq: ACLS), based in Beverly, Mass., has announced its participation in two upcoming investor conferences. The first is the Susquehanna Financial Group Twelfth Annual Technology Conference, scheduled for March 2-3, 2023, at the Lotte New York Palace Hotel. Management will hold one-on-one meetings with investors on March 2. The second event is the Loop Capital Markets 2023 Investor Conference, taking place virtually on March 13 and in-person on March 14, 2023, also at the Lotte New York Palace Hotel, with one-on-one meetings on the latter date. Axcelis has over 40 years of experience providing ion implantation solutions for the semiconductor industry.
Axcelis Technologies reported a record annual revenue of $920 million for 2022, a 39% increase from $662.4 million in 2021. The company's gross margin improved to 43.7% while net income rose to $183.1 million, or $5.46 per diluted share, reflecting an 86% year-over-year increase. For Q4 2022, revenue was $266.1 million, with a gross margin of 41.2%. Looking ahead, Axcelis expects first-quarter revenue of approximately $240 million and over $1 billion for the full year 2023. The company also introduced a new revenue model projecting $1.3 billion in the next 2-3 years.
Axcelis Technologies (Nasdaq: ACLS), a leader in semiconductor solutions, announced that its President and CEO, Mary Puma, has been elected Chairperson of the International Board of Directors of SEMI. This significant role allows her to lead the evolution of SEMI's operations and services globally. Puma, who has served on the SEMI board since 2003, aims to address the challenges and opportunities facing equipment and materials companies in the semiconductor technology supply chain. The SEMI board comprises representatives from various regions, including Europe, China, and North America, reflecting its global reach.
Axcelis Technologies, Inc. (Nasdaq: ACLS), a key player in the semiconductor industry, announced follow-on shipments of its Purion H™ high current implanters to various fabs. This development supports the ramp-up of advanced logic device technology manufacturing. Shipped in Q4 2022, these systems provide unmatched levels of process control, throughput, and uniformity, enabling chip manufacturers to enhance yield while minimizing ownership costs. Executive Vice President Greg Redinbo highlighted the innovative architecture of the Purion H, designed specifically for advanced memory and logic applications.
Axcelis Technologies (Nasdaq: ACLS) will showcase its Purion™ platform at SEMICON Korea 2023 from February 1-3 at COEX Center, Seoul. This event highlights their cutting-edge ion implanters including the Purion H™ Series, Purion XE™ Series featuring patented Boost Technology™, and the Purion Power Series designed for diverse wafer types. The company emphasizes its in-country manufacturing capabilities and local supply chain in Korea, a key market in the Asia Pacific region. President and CEO Mary Puma highlighted the importance of delivering advanced technology to Korean chipmakers.